Overview
The Neurology Update Symposium provides an evidence-based review on recent advances in the diagnosis and treatment of common neurological disorders. The program covers the latest guidelines, clinical strategies and recent advances, including new approaches for diagnosis and expanded options for treatment. Topics include endovascular therapy for acute stroke, vascular dementia, central apnea, obstructive sleep apnea, multiple sclerosis, mobile stroke units, inflammatory myopathies, restless leg syndrome, epilepsy, and neuro-ethics.
We encourage speakers to focus on clinically meaningful information and to use a case based approach. Our
educational format includes didactic lectures and case presentations with discussion and time for Q & A.
Course Learning Objectives:
Upon completion of this program, participants will be able to:
1. Summarize diagnostic and treatment advances in endovascular therapies for acute stroke, vascular dementia, epilepsy, multiple sclerosis, restless leg syndrome and neuromuscular disorders.
2. Summarize the benefits of stroke treatment delivered my Mobile Stroke Unites and the current status of the
ongoing BEST MSU Trial.
3. Discuss advances in the diagnosis, management and treatment of patients with central apnea and obstructive
sleep apnea.
4. Discuss Cannabinoids for treatment of epilepsy and current approval status in Texas.
5. Recognize some ethical implications of aspects of neurological care.
We encourage speakers to focus on clinically meaningful information and to use a case based approach. Our
educational format includes didactic lectures and case presentations with discussion and time for Q & A.
Course Learning Objectives:
Upon completion of this program, participants will be able to:
1. Summarize diagnostic and treatment advances in endovascular therapies for acute stroke, vascular dementia, epilepsy, multiple sclerosis, restless leg syndrome and neuromuscular disorders.
2. Summarize the benefits of stroke treatment delivered my Mobile Stroke Unites and the current status of the
ongoing BEST MSU Trial.
3. Discuss advances in the diagnosis, management and treatment of patients with central apnea and obstructive
sleep apnea.
4. Discuss Cannabinoids for treatment of epilepsy and current approval status in Texas.
5. Recognize some ethical implications of aspects of neurological care.
Accreditation and Credits
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and The University of Texas Health Science Center at Houston. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ethics presentation, End of Life, has been designated by Baylor College of Medicine for 1.0 credit of education in medical ethics and/or professional responsibility.
CNE: This activity has been approved for CNE-The University of Texas Health Science Center at Houston School of Nursing is an approved provider of continuing education by the Texas Nurses Association- Approver, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 7.5 contact hours on Nursing continuing education.
Target Audience: We will be providing a full day CME accredited program for neurologists, internists, family practitioners, nurse practitioners, nurses and other allied healthcare providers who diagnosis and treat people with neurological diseases and disorders.
Educational Format: Includes lectures, case presentations with discussion and Q & A. Speakers are encouraged to focus on clinically meaningful information and to use a case based approach.
Baylor College of Medicine designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ethics presentation, End of Life, has been designated by Baylor College of Medicine for 1.0 credit of education in medical ethics and/or professional responsibility.
CNE: This activity has been approved for CNE-The University of Texas Health Science Center at Houston School of Nursing is an approved provider of continuing education by the Texas Nurses Association- Approver, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 7.5 contact hours on Nursing continuing education.
Target Audience: We will be providing a full day CME accredited program for neurologists, internists, family practitioners, nurse practitioners, nurses and other allied healthcare providers who diagnosis and treat people with neurological diseases and disorders.
Educational Format: Includes lectures, case presentations with discussion and Q & A. Speakers are encouraged to focus on clinically meaningful information and to use a case based approach.